The global Ultrasound-Guided Breast Biopsy market sales is anticipated to reach US$ 1,090 million by 2032, growing at an 8% CAGR during the forecast period. In 2022, the ultrasound-guided biopsy market is expected to be worth US$ 720 million. Throughout the projected period, market sales will be driven by the rising prevalence of breast cancer cases and increased awareness about early detection of breast cancer.
The thorough research contains market revenue numbers, segment-specific data, regional data, and country-specific data, as well as an in-depth commentary on the main influencing elements. This is one of the most thorough studies, encompassing all facets of the growing Ultrasound Guided Breast Biopsy sector.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-9580
Ultrasound-Guided Breast Biopsy: Market Insights
Breast cancer is one of the most common types of cancer in women, affecting over 80% of women over the age of 50. Breast cancer typically begins in the breast tissue, which is composed of glands for milk production known as lobules, or in the ducts.
Breast abnormalities or lumps are typically discovered via mammography, physical examination, and other imaging techniques. Thus, Ultrasound-Guided Breast Biopsy was introduced into the market, which involves taking certain abnormality samples under the direction of MRI or mammography, as well as ultrasound.
A radiologist employed ultrasound imaging to direct to the region of aberrant cell development in Ultrasound-Guided Breast Biopsy. An Ultrasound-Guided Breast Biopsy is typically conducted when an anomaly arises, such as a distortion in the structure of the breast tissue, a suspicious mass of solid, or an area of change of abnormal tissue.
According to the World Health Organisation, an estimated 627,000 women died from breast cancer worldwide in 2018. As the occurrence of breast cancer rises, the market for Ultrasound-Guided Breast Biopsy is expected to expand.
Ultrasound-Guided Breast Biopsy: Market Dynamics
Because it is less invasive than other surgical biopsy methods, ultrasound-guided breast biopsy is predicted to increase significantly in the market. Furthermore, Ultrasound-Guided Breast Biopsy leaves less scar and may be conducted in a short period of time, which will enhance the adoption rate of Ultrasound-Guided Breast Biopsy.
Aside from that, no ionising radiation is utilised in Ultrasound-Guided Breast Biopsy imaging, which provides faster results and is expected to fuel the Ultrasound-Guided Breast Biopsy market expansion. Furthermore, the Ultrasound-Guided Breast Biopsy is less expensive and takes less time to recover from.
Contact Us for a Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-9580
All of these elements will help to the expansion of the Ultrasound-Guided Breast Biopsy market. However, various constraints are impeding the growth of the Ultrasound-Guided Breast Biopsy market. During the biopsy, some factors, such as the risk of hematoma formation, may emerge.
Furthermore, patients may experience discomfort during the biopsy, which may have an impact on the growth of the Ultrasound-Guided Breast Biopsy market. The cost of the device is another key factor limiting market growth.
Ultrasound-Guided Breast Biopsy Market: Overview
Ultrasound-Guided Breast Biopsy is expected to drive market expansion. With the rising prevalence and rates of breast cancer, the Ultrasound-Guided Breast Biopsy market is expected to expand significantly.
Manufacturers are now concentrating their efforts on developing new imaging technologies for the proper treatment of breast cancer. Ultrasound-Guided Breast Biopsy is gaining popularity among other procedures since it offers results in less time and reduces the length of patients’ stay, and so Ultrasound-Guided Breast Biopsy will boost market expansion.
Ultrasound-Guided Breast Biopsy Market: Key Players
Some of the key players present across the value chain of the global Ultrasound-Guided Breast Biopsy market are Hologic, Inc., Medsurge Ind Private Limited
Key Segments Profiled in the Ultrasound-Guided Breast Biopsy Market Survey
By Procedure:
- Fine needle aspiration (FNA) Ultrasound-Guided Breast Biopsy
- Core needle (CN) Ultrasound-Guided Breast Biopsy
- Vacuum-assisted device (VAD) Ultrasound-Guided Breast Biopsy
- Wire localization Ultrasound-Guided Breast Biopsy
By End User:
- Hospitals
- Clinics
- Diagnostics Laboratories
- Others
Visit for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-9580
The regional analysis includes
- North America (US, Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- The Middle East and Africa (GCC, S. Africa, N. Africa)
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs